New sequencing studies shed more light on the B.1.1.7 SARS-CoV-2 variant

3

Two new studies have shed light on the B.1.1.7 variant, suggesting that while it is more transmissible, it does not increase severity.

The B.1.1.7 variant of SARS-CoV-2 was first identified in the UK in December 2020, and is now one of three well-known variants – including P.1 (first identified in Brazil) and B.1.351 (first identified in South Africa) – that have triggered a wave of efforts to examine their impact on epidemiology and the efficacy of vaccines and therapeutics.

READ MORE ON BIOTECHNIQUES NOW

Share:

3 Comments

  1. Too many mutations in the coding sequence for the S protein could cause the virus to loose its ability to bind to the human receptor.

    Therefore, it follows that antibodies would still function on binding the vital protein. Just my thoughts. Thanks

  2. Can’t get Two new studies have shed light on the B.1.1.7 variant, suggesting that while it is more transmissible, it does not increase severity to open

Reply To Mingquan Guo Cancel Reply